* DarioHealth Corp DRIO.OQ reported a quarterly adjusted
loss
of 8 cents per share for the quarter ended in June, higher
than the same quarter last year, when the company reported EPS
of -58 cents. The mean expectation of two analysts for the
quarter was for a loss of 56 cents per share. Wall Street
expected results to range from -60 cents to -51 cents per share.
* Revenue rose 1.7% to $6.26 million from a year ago;
analysts
expected $7.91 million.
* DarioHealth Corp's reported EPS for the quarter was a loss
of 8
cents.
* The company reported a quarterly loss of $13.61 million.
* DarioHealth Corp shares had fallen by 22.1% this
quarter and
lost 46.1% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 33.7%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for DarioHealth Corp
is $4.50
This summary was machine generated from LSEG data August 8 at
02:22 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 -0.55 -0.08 Beat
Mar. 31 2024 -0.40 -0.20 Beat
Dec. 31 2023 -0.55 -0.50 Beat
Sep. 30 2023 -0.46 -0.49 Missed